Blue Trust Inc. Sells 134 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Blue Trust Inc. decreased its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 17.1% in the 4th quarter, Holdings Channel.com reports. The firm owned 651 shares of the medical instruments supplier’s stock after selling 134 shares during the quarter. Blue Trust Inc.’s holdings in ICU Medical were worth $101,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in ICUI. FMR LLC lifted its stake in ICU Medical by 2,676.6% in the 3rd quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier’s stock valued at $18,968,000 after purchasing an additional 100,345 shares during the last quarter. State Street Corp lifted its stake in ICU Medical by 9.3% in the 3rd quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier’s stock valued at $165,384,000 after purchasing an additional 77,506 shares during the last quarter. Geode Capital Management LLC lifted its stake in ICU Medical by 9.6% in the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock valued at $99,687,000 after purchasing an additional 48,106 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in ICU Medical by 10.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier’s stock valued at $54,868,000 after purchasing an additional 27,927 shares during the last quarter. Finally, Principal Financial Group Inc. increased its position in ICU Medical by 24.6% in the 3rd quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier’s stock valued at $23,130,000 after acquiring an additional 25,031 shares during the period. Institutional investors own 96.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on ICUI. StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, November 20th. Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. Jefferies Financial Group upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target for the company in a research report on Wednesday, December 11th. Finally, KeyCorp upped their price target on shares of ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research report on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, ICU Medical has an average rating of “Moderate Buy” and an average price target of $199.67.

ICU Medical Stock Performance

Shares of ICUI opened at $157.42 on Friday. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The company has a market capitalization of $3.85 billion, a price-to-earnings ratio of -34.45 and a beta of 0.63. The stock has a 50 day moving average of $160.74 and a 200 day moving average of $165.91. ICU Medical, Inc. has a 12 month low of $93.36 and a 12 month high of $196.26.

Insider Buying and Selling at ICU Medical

In related news, COO Christian B. Voigtlander sold 1,962 shares of the stock in a transaction on Monday, November 25th. The stock was sold at an average price of $169.08, for a total value of $331,734.96. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Vivek Jain sold 12,000 shares of the stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $162.91, for a total value of $1,954,920.00. Following the completion of the sale, the chief executive officer now owns 104,593 shares in the company, valued at $17,039,245.63. This trade represents a 10.29 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 17,737 shares of company stock valued at $2,879,752. Company insiders own 6.70% of the company’s stock.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.